Abstract:Androgenetic alopecia (AGA in men/female pattern hair loss FPHL in women) has been associated with the most frequent culprit of hair loss concerning both men and women. It may be viewed as chronic, progressive, non scarring type of hair loss. The main factor in its pathophysiological mechanism plays genetic susceptibility to androgens of certain individuals. Increased level of androgens shown to be the cause in men, whereas in women this level may be elevated or normal. For the management of the condition topical treatment with minoxidil has been approved, as well as orally administered finasteryd, spironolakton or dutasteride. Aim: The main objective of this research project was to study the patients with AGA in terms of gender, age, prescribed treatment and hormone dysfunctions. Materials and methods: The analyzed population consisted of 104 patients treated in dermatology department in Cracow in three years period (2015-2018) for AGA. Initially, demographic characteristics and treatment were tested. The next step of the analysis was the comparison of groups according to gender and, what is more among women according to age (up to 45 and >45 years of age). Statistical analysis was performed with U Mann-Whitney and Chi square Pearsons tests. Results: The majority of patients participating in the study were women (87,5%). The average age of the study population was 45,5±15,5 years of age. The most frequently ordered medicine was minoxidil 5% solution (82,2% of patients), besides polytherapy of two medicines were applied in 45,8% of patients. In the study group hypothyroidism was observed in 10.6% of patients. The examined group of women were older than men (48.3 vs. 25.8 years; p<0.0001). Male patients were more often ordered systemic treatment (52.9 vs.15,4%; p=0.0012), whereas topical treatment was more often applied to women (94.5 vs. 69.2; p=0.0024). Women usually were ordered more than one medicine in contrast to men (44.0 vs. 15.4%; p=0.0495). Therefore no significant difference between women up to 45 and >45 years of age was observed. Conclusions: Statistically significant occurrence of hypothyroidism was observed. Therefore this connection requires further studies. Other endocrinological dysfunctions like acne, hirsutism or menstrual disorder were relatively rare.

Serum uric acid level in male patients with androgenetic alopecia: A prospective study in China

Serum Levels of Androgen-Associated Hormones Are Correlated with Curative Effect in Androgenic Alopecia in Young Men

Evaluation of efficacy and safety of finasteride 1 mg/d in the treatment of androgenetic alopecia in Hangzhou region

Association Between Serum Uric Acid Levels and Dyslipidemia in Chinese Adults: A Cross-Sectional Study and Further Meta-Analysis.

Comparison of a New 5% Minoxidil Foam and Rogaine® in the Treatment of Androgenetic Alopecia in Chinese Men: A Randomized, Double-Blind, Phase III, Equivalence Trial

A Double Blind Randomized Placebo Controlled Clinical Trial of Finasteride in the Treatment of Androgenetic Alopecia

Clinical Value Of Serum Lipid Profile And Renal Function For The Management Of Hyperuricemia In Adults In Southern China

Homocysteine in androgenetic alopecia: A case control study and observational experiments on mice

Investigation of Oral Finasteride Enhanced Occipital Hair Diameter Index in Different Types of Male Androgenetic Alopecia.

Relationship Between Serum Uric Acid and Selected Cardiovascular Risk Factors in Hangzhou Populations

Change in Prostate Specific Antigen Concentration in Men with Prostate Specific Antigen Less than 2.5 ng/ml Taking Low Dose Finasteride or Dutasteride for Male Androgenetic Alopecia

Effect of hair care products containing zinc pyrithione, pollen extract, sachitin and other ingredients assisted with finasteride on androgenic alopecia

Combined treatment with oral finasteride and topical minoxidil in male androgenetic alopecia: a randomized and comparative study in Chinese patients

Urate-lowering agents do not have clinically relevant negative effects on sperm quality and reproductive hormones in men with gout: a prospective open-label cohort study

Effects of high serum uric acid levels on oxidative stress levels and semen parameters in male infertile patients

Favorable effect of herbal extract on androgenic alopecia: A case report

Comparative efficacy of various treatment regimens for androgenetic alopecia in men

Evaluating treatments for male androgenetic alopecia: clinical profile and comparative efficacy of platelet rich plasma and minoxidil with finasteride

Analysis of influencing factors to the therapeutic effect of androgenetic alopecia

Methods of treatment patients with androgenetic alopecia based on reference of Department of Dermatology in Cracow

Association between serum uric acid and prostate cancer mortality in androgen deprivation therapy: A population‐based cohort study